Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

5/7/2021
BreakingIOLRegulation
J&J Vision Gains US Approval of TECNIS Synergy and Synergy Toric II, Canadian Approval of Toric II
J&J Vision Gains US Approval of TECNIS Synergy and Synergy Toric II, Canadian Approval of Toric II

Johnson & Johnson Vision announced May 6 that it had gained US FDA approval for its TECNIS Synergy and Synergy Toric II IOLs, plus Health Canada approval for the Synergy Toric II IOLs. The Synergy ...

5/7/2021
BreakingCataractRefractiveSurgical
Ziemer Introduces Femto Z8 Neo Multipurpose Cataract-Refractive Laser
Ziemer Introduces Femto Z8 Neo Multipurpose Cataract-Refractive Laser

Swiss company Ziemer has introduced a new femtosecond laser, the Femto Z8 Neo—the successor to its LDV Z8. The multipurpose cataract, refractive, and therapeutic laser system has a small, wheeled p...

5/7/2021
BreakingCataractIOLSurgical
Ophtec Introduces PC-Toric Version of its Precizon IOL
Ophtec Introduces PC-Toric Version of its Precizon IOL

Dutch company Ophtec announced May 1 that it had introduced the Precizon Presbyopic Toric IOL, which combines the features of the company’s Precizon Toric and Precizon Presbyopic lenses. Ophtec tou...

5/7/2021
BreakingCataractGlaucomaLaserRetinaRevenue
Q1-2021 Revenue Roundup: Alcon, Bausch + Lomb, Regeneron, Eight More
Q1-2021 Revenue Roundup: Alcon, Bausch + Lomb, Regeneron, Eight More

Alcon reported May 4 that its Q1-2021 net sales totaled $1.9 billion, a 5 percent increase over $1.8 billion in Q1-2020. David Endicott, chief executive officer, called the first quarter a solid st...

5/7/2021
BreakingDeviceDry EyeRegulation
Lumenis Receives US FDA Approval for OptiLight IPL Device to Manage Dry Eye
Lumenis Receives US FDA Approval for OptiLight IPL Device to Manage Dry Eye

Israel’s Lumenis announced April 29 that the US FDA had granted de novo authorization for OptiLight, the company’s newest intense pulsed light (IPL) device for improving signs of dry eye disease du...

5/7/2021
BreakingClinical TrialPharmaRetina
Sandoz Readies for Phase III Trial of Proposed Aflibercept Biosimilar
Sandoz Readies for Phase III Trial of Proposed Aflibercept Biosimilar

Novartis’ Sandoz division said May 3 that it was in late-stage development of a proposed biosimilar of retinal drug aflibercept (Eylea). Sandoz said it would begin enrolling the first patient in a ...

5/7/2021
BreakingRegulation
US Appeals Court Ruling Prevents FDA from Regulating Devices as Drugs
US Appeals Court Ruling Prevents FDA from Regulating Devices as Drugs

A US appeals court ruling April 16 will make it harder for the FDA to regulate medical technology as a drug when it meets the definition of a device. The decision by the DC Circuit Court of Appeals...

5/7/2021
BreakingRegulation
FDA to Create New Method for Approving Old Drugs
FDA to Create New Method for Approving Old Drugs

The US FDA is reviewing how to replace the Unapproved Drugs Initiative, a program launched in 2006 to encourage manufacturers to seek approval for drugs that were in use before 1938, when the FDA b...

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

United States
US Surveys
May select more than one